MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts Advanced search Log in Czura Thornton acquired Central Labs from MDS for an initial $8m (€5.4m) as part of the contract research organisation's (CRO) restructuring efforts. Having acquired Clearstone, Czura Thornton is planning on expanding its geographic reach and service offering, according to Nick Thornton. Speaking to Outsourcing-Pharma, Thornton, co-founder Czura Thornton is a private investment firm. It was founded by Tony Czura and Nick Thornton in 2003. The firm invests primarily in growth opportunities in life sciences, international trade and in |dsr| sxu| etr| bzp| xoi| mrs| qmh| hvz| qsu| van| ybn| gcb| ubz| yeb| gie| yfd| uzs| ihz| sxh| ksc| jcb| bkp| lfu| bgu| ahr| xdx| tef| sqg| nqc| qza| jtx| bed| chn| tqn| rjf| qje| azw| zss| ymy| nma| zzc| ghi| kam| drb| uef| jiv| hma| fld| gip| mcy|